Banting, G. S. et al. CECR2, a protein involved in neurulation, forms a novel chromatin remodeling complex with SNF2L. Hum. Mol. Genet. 14, 513-524

Department of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada.
Human Molecular Genetics (Impact Factor: 6.39). 03/2005; 14(4):513-24. DOI: 10.1093/hmg/ddi048
Source: PubMed


Chromatin remodeling complexes play critical roles in development. Here we describe a transcription factor, CECR2, which is involved in neurulation and chromatin remodeling. CECR2 shows complex alternative splicing, but all variants contain DDT and bromodomain motifs. A mutant mouse line was generated from an embryonic stem cell line containing a genetrap within Cecr2. Reporter gene expression demonstrated Cecr2 expression to be predominantly neural in the embryo. Mice homozygous for the Cecr2 genetrap-induced mutation show a high penetrance of the neural tube defect exencephaly, the human equivalent of anencephaly, in a strain-dependent fashion. Biochemical isolation of CECR2 revealed the presence of this protein as a component of a novel heterodimeric complex termed CECR2-containing remodeling factor (CERF). CERF comprises CECR2 and the ATP-dependent chromatin remodeler SNF2L, a mammalian ISWI ortholog expressed predominantly in the central nervous system. CERF is capable of remodeling chromatin in vitro and displays an ATP hydrolyzing activity that is stimulated by nucleosomes. Together, these data identify a novel chromatin remodeling complex with a critical role in neurulation.

Download full-text


Available from: Heather E McDermid, Jul 21, 2015
  • Source
    • "Other studies highlight a more global role for ISWI in chromatin compaction (Corona et al., 2007; Li et al., 2010). The Snf2l protein is part of two different complexes, CERF (Banting et al., 2005) and NURF (Barak et al., 2003), but which one regulates Foxg1 expression is unclear. The NURF complex is largely considered an activator of gene expression, whereas the function of the CERF complex remains unknown (Lazzaro et al., 2006; Wysocka et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Balancing progenitor cell self-renewal and differentiation is essential for brain development and is regulated by the activity of chromatin remodeling complexes. Nevertheless, linking chromatin changes to specific pathways that control cortical histogenesis remains a challenge. Here we identify a genetic interaction between the chromatin remodeler Snf2l and Foxg1, a key regulator of neurogenesis. Snf2l mutant mice exhibit forebrain hypercellularity arising from increased Foxg1 expression, increased progenitor cell expansion, and delayed differentiation. We demonstrate that Snf2l binds to the Foxg1 locus at midneurogenesis and that the phenotype is rescued by reducing Foxg1 dosage, thus revealing that Snf2l and Foxg1 function antagonistically to regulate brain size.
    Developmental Cell 04/2012; 22(4):871-8. DOI:10.1016/j.devcel.2012.01.020 · 9.71 Impact Factor
  • Source
    • "During Neurulation Cecr2 Is Expressed in Both the Neural Epithelium and Head Mesenchyme To better understand the role of Cecr2 during neurulation, we examined its expression during this time using the LacZ fusion protein of the Cecr2 Gt45Bic mutation. Xgal staining at 13.5 days post coitus (dpc) previously showed that Cecr2 is expressed in the nervous system (brain, spinal cord, spinal ganglia , and forming retina), as well as the nasal epithelium, lens, limb, and intercostal mesenchyme (Banting et al., 2005). Whole-mount embryos at 9.5 dpc showed Xgal staining along the closed neural tube. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The loss of Cecr2, which encodes a chromatin remodeling protein, has been associated with the neural tube defect (NTD) exencephaly and open eyelids in mice. Here, we show that two independent mutations of Cecr2 are also associated with specific inner ear defects. Homozygous mutant 18.5 days post coitus (dpc) fetuses exhibited smaller cochleae as well as rotational defects of sensory cells and extra cell rows in the inner ear reminiscent of planar cell polarity (PCP) mutants. Cecr2 was expressed in the neuroepithelium, head mesenchyme, and the cochlear floor. Although limited genetic interaction for NTDs was seen with Vangl2, a microarray analysis of PCP genes did not reveal a direct connection to this pathway. The mechanism of Cecr2 action in neurogenesis and inner ear development is likely complex.
    Developmental Dynamics 02/2011; 240(2):372-83. DOI:10.1002/dvdy.22547 · 2.38 Impact Factor
  • Source
    • "The CECR1 gene was expressed in the outflow tract and atrium of the heart and in the VII/VIII cranial nerve ganglion, suggesting its potential involvement in CES heart and facial defects (17). The other gene, CECR2, encodes for a putative transcriptional coactivator involved in neurulation and chromatin remodeling, particularly during later brain development and in the eye (18). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The 22q11 region has been implicated in chromosomal rearrangements that result in altered gene dosage, leading to three different congenital malformation syndromes: DiGeorge syndrome, cat-eye syndrome (CES), and der(22) syndrome. Although DiGeorge syndrome is a common genomic disorder on 22q11, CES is quite rare, and there has been no report of Korean CES cases with molecular cytogenetic confirmation. In this study, we present the phenotypic and genetic characteristics of a 3-month-old boy with CES. Clinical findings included micropthalmia, multiple colobomata, and renal and genital anomalies. Cytogenetic analyses showed the presence of a supernumerary marker chromosome, which was identified as a bisatellited and isodicentric chromosome derived from an acrocentric chromosome. The results of array comparative genomic hybridization and fluorescence in situ hybridization studies confirmed the karyotype as 47,XY,+mar.ish idic(22)(q11.1) (D22S43+).arr 22q11.1(15,500,000-15,900,000)x4, resulting in a partial tetrasomy of 22q11.1. To the best of our knowledge, this is the first report in Korea of CES confirmed by cytogenetic and molecular cytogenetic analyses.
    Journal of Korean medical science 12/2010; 25(12):1798-801. DOI:10.3346/jkms.2010.25.12.1798 · 1.27 Impact Factor
Show more